MWI drugs

6 results

Atropine (atropine sulfate)

(Atropine Sulfate)
MWI
Usage: Atropine Sulfate Ophthalmic Solution, USP 1% is indicated for cycloplegia, mydriasis, and penalization of the healthy eye in the treatment of amblyopia.
MWI
Usage: Erythromycin is indicated for treating superficial ocular infections of the conjunctiva and cornea caused by susceptible organisms. It also serves as prophylaxis for ophthalmia neonatorum due to *N. gonorrhoeae* or *C. trachomatis*, although its effectiveness against penicillinase-producing *N. gonorrhoeae* is unestablished.
MWI
Usage: This drug is indicated for steroid-responsive inflammatory ocular conditions with a risk of bacterial infection, such as conjunctivitis, chronic anterior uveitis, and corneal injuries. It contains an anti-infective component effective against common bacterial eye pathogens while not adequately covering certain strains like Serratia marcescens and Streptococcus pneumoniae.
MWI
Usage: Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone Ophthalmic Ointment is indicated for steroid-responsive inflammatory ocular conditions with a risk of bacterial infection, including conjunctival and corneal inflammation, chronic anterior uveitis, and corneal injuries. It targets several common bacterial pathogens but not Serratia marcescens.
MWI
Usage: Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment is indicated for the topical treatment of superficial external eye infections caused by susceptible bacteria, including conjunctivitis, keratitis, keratoconjunctivitis, blepharitis, and blepharoconjunctivitis.
MWI
Usage: Proparacaine Hydrochloride Ophthalmic Solution is indicated for topical anesthesia in ophthalmic procedures, including tonometry, removal of foreign bodies and sutures, conjunctival scraping, gonioscopic examinations, and as a topical anesthetic prior to surgical operations like cataract extraction.